Hemoglobin Control, ESA Resistance, and Regular Low-Dose IV Iron Therapy: A Review of the Evidence
Author:
- 1 January 2009
- journal article
- review article
- Published by Wiley in Seminars in Dialysis
- Vol. 22 (1) , 64-69
Abstract
Anemia management in hemodialysis patients has progressed following the introduction of erythropoiesis‐stimulating agents (ESAs) and intravenous (IV) iron. However, maintaining a stable hemoglobin (Hb) level can be challenging. Patient comorbidities and variable dosage administrations of ESA therapy can lead to great variability in Hb concentrations over time. Fluctuating Hb levels is associated with increased complications. This article reviews factors that affect Hb control, with a focus on management practices (e.g., regular low‐dose administration of IV iron) that can help improve anemia management.Keywords
This publication has 27 references indexed in Scilit:
- Iron deficiency in non-dialysis chronic kidney diseaseKidney International, 2009
- Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomesKidney International, 2008
- Hemoglobin Level VariabilityClinical Journal of the American Society of Nephrology, 2008
- Hemoglobin Variability and Mortality in ESRDJournal of the American Society of Nephrology, 2007
- Maintaining control over haemoglobin levels: optimizing the management of anaemia in chronic kidney diseaseNephrology Dialysis Transplantation, 2007
- Correction of Anemia with Epoetin Alfa in Chronic Kidney DiseaseNew England Journal of Medicine, 2006
- Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietinKidney International, 2005
- Continuous Intravenous Sodium Ferric Gluconate Improves Efficacy in the Maintenance Phase of EPOrHu Administration in Hemodialysis PatientsAmerican Journal of Nephrology, 2002
- Components of biological, including seasonal, variation in hematological measurements and plasma fibrinogen concentrations in normal humansCellular and Molecular Life Sciences, 1995
- Separate hemoglobin standards for blacks and whites: A critical review of the case for separate and unequal hemoglobin standardsMedical Hypotheses, 1990